You are here

  • Home
  • Archive
  • Volume 107, Issue 8
  • Is recombinant tissue plasminogen activator treatment a safe choice in very and extremely preterm infants with intracardiac thrombosis?

Article info

Article menu
Download PDFPDF
Archimedes
Is recombinant tissue plasminogen activator treatment a safe choice in very and extremely preterm infants with intracardiac thrombosis?

Authors

  1. Correspondence to Dr Iuri Corsini, Division of Neonatology, Careggi University Hospital, 50134 Firenze, Italy; corsiniiuri{at}gmail.com
View Full Text

Citation

Ciarcià M, Corsini I, Miselli F, et al
Is recombinant tissue plasminogen activator treatment a safe choice in very and extremely preterm infants with intracardiac thrombosis?
Archives of Disease in Childhood 2022;107:772-775.

Publication history

  • Received January 3, 2022
  • Accepted April 22, 2022
  • First published May 10, 2022.
Online issue publication 
October 18, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.